Revenue (Quarterly) Chart

View Revenue (Quarterly) for SUGR.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 180.81M
March 31, 2026 204.65M
December 31, 2025 208.33M
September 30, 2025 182.98M
June 30, 2025 320.44M
March 31, 2025 222.75M
December 31, 2024 223.84M
September 30, 2024 234.59M
June 30, 2024 188.81M
Date Value
March 31, 2024 249.18M
December 31, 2023 156.01M
September 30, 2023 186.42M
June 30, 2023 158.71M
March 31, 2023
December 31, 2022 128.26M
September 30, 2022 109.72M
June 30, 2022 169.67M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Rhelion Life Sciences Corp. 0.8753M
TelyRx Holdings, Inc. 31.38M
George Weston Ltd. 15.20B
Loblaw Cos. Ltd. 15.05B
Empire Co. Ltd. 7.807B